FDA Approves Aegerion's Cholesterol Drug Juxtapid

Aegerion Pharmaceuticals announced that the U.S. Food and Drug Administration has approved use of Juxtapid (lomitapide) pills as an accompaniment to a low-fat diet and other lipid-lowering treatments. Juxtapid is for patients with homozygous familial hypercholesterolemia (HoFH), a critical, uncommon genetic disease that inhibits the function of the receptor that eliminates bad cholesterol from the body. This loss of function of the LDL receptor function causes high levels of cholesterol in the blood... (Source: Health News from Medical News Today)

Source: http://www.medworm.com/index.php?rid=6876997&cid=u_0_26_f&fid=23292&url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2Fmnt%2Fhealthnews%2F%7E3%2FUHhQTImhl4c%2F254468.php

phlebotomy training illinois phlebotomy courses in nj phlebotomy training in illinois